Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo ...

Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows.

Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs. The drugs have risen in popularity for diabetic patients and ...

U.S. Senator Bernie Sanders announced that pharmacy benefit managers have agreed to expand coverage for Novo Nordisk's ...

Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

Novo Nordisk Chief Executive Lars Jorgensen challenged Medicare's new role negotiating prescription drug prices during his testimony before a Senate committee on the company's blockbuster diabetes and ...

On Tuesday, the CDC’s National Center for Health Statistics released its latest report analyzing data on the state of obesity ...

A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...

WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo ...

Novo Nordisk CEO has cautioned that reducing drugs’ list prices can carry harmful unintended consequences for patients’ ...

U.S. Senator Bernie Sanders announced commitments from all major pharmacy benefit managers (PBMs) to expand coverage of Novo Nordisk's diabetes and weight-loss drugs, Ozempic and Wegovy, if the ...

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, faced tough questions on Capitol Hill Tuesday as lawmakers pressed the company ...